Ad
related to: immunogen
Search results
ImmunoGen (IMGN) Stock Down Despite Q2 Earnings & Sales Beat
Zacks via Yahoo Finance· 10 months agoImmunoGen's (IMGN) Q2 earnings show an encouraging adoption of the sole-marketed drug Elahere. The...
ImmunoGen (IMGN) Gets Accelerated FDA Approval for Ovarian Cancer Drug
Zacks via Yahoo Finance· 2 years agoImmunoGen (IMGN) receives accelerated FDA approval for its lead drug mirvetuximab soravtansine-gynx,...
ImmunoGen (IMGN) Enters New Collaboration to Boost ADC Pipeline
Zacks via Yahoo Finance· 2 years agoImmunoGen (IMGN) inks a collaboration deal with privately-held Oxford BioTherapeutics to develop...
ImmunoGen (IMGN) Q2 Earnings and Revenues Miss Estimates
Zacks via Yahoo Finance· 2 years agoImmunoGen, Inc. IMGN incurred a loss of 24 cents per share for second-quarter 2022, wider than the...
Institutional investors in ImmunoGen, Inc. (NASDAQ:IMGN) lost 9.0% last week but have reaped the...
Simply Wall St. via Yahoo Finance· 10 months agoKey Insights Given the large stake in the stock by institutions, ImmunoGen's stock price might be...
ImmunoGen (IMGN) Reports Q3 Loss, Tops Revenue Estimates
Zacks via Yahoo Finance· 2 years agoImmunoGen (IMGN) delivered earnings and revenue surprises of -19.23% and 30.16%, respectively, for...
When Will ImmunoGen, Inc. (NASDAQ:IMGN) Breakeven?
Simply Wall St. via Yahoo Finance· 1 year agoImmunoGen, Inc. (NASDAQ:IMGN) is possibly approaching a major achievement in its business, so we would like to shine some light on the company....
ImmunoGen (IMGN) Stock Surges 230% in a Month: Here's Why
Zacks via Yahoo Finance· 1 year agoImmunoGen (IMGN) shares surge exponentially in the past month owing to the positive data on the...
ImmunoGen Allows Vertex Pharma Use Its Technology For Conditioning Agents For Use With Gene Editing
Benzinga via Yahoo Finance· 1 year agoImmunoGen Inc (NASDAQ: IMGN) announced a global, multi-target license and option agreement that...
Are Investors Undervaluing ImmunoGen, Inc. (NASDAQ:IMGN) By 38%?
Simply Wall St. via Yahoo Finance· 5 months agoKey Insights The projected fair value for ImmunoGen is US$47.87 based on 2 Stage Free Cash Flow to...